What's Happening?
Scientists at the Salk Institute and the Arc Institute have released a comprehensive single-cell atlas that maps two major epigenetic systems: three-dimensional genome folding and DNA methylation. This atlas, part of the NIH 4D Nucleome program, spans
86,689 cells from 16 human tissues, revealing 35 major cell types and 206 subtypes. The research highlights the importance of understanding genome organization in regulating gene expression in health and disease. The atlas identifies over 1.36 million differentially methylated regions and 283,606 differential chromatin loops, providing insights into how genetic variants impact disease. The study also challenges previous assumptions about non-CG methylation, showing its presence across various human tissues.
Why It's Important?
This research is significant as it provides a new resource for understanding the complex interactions between genetic variants and disease. By mapping the 3D genome and DNA methylation together, scientists can better understand how genetic variants in noncoding regions contribute to disease. This atlas could aid in identifying which cell types are more vulnerable to genetic variants, potentially leading to more targeted therapies. The findings also offer a new perspective on cell differentiation and the role of epigenetic features in disease progression, which could reshape how researchers approach the study of diseases like cancer.
What's Next?
The atlas is expected to serve as a valuable resource for future research, particularly in understanding the functional impact of genetic variants. The data is freely available online, allowing researchers to explore DNA methylation and 3D chromatin contacts across various tissues and cell types. This could facilitate the development of new AI tools to predict disease risk and inform therapeutic strategies. The NIH 4D Nucleome consortium aims to extend this mapping into the fourth dimension, exploring how genome structure and chemistry change over time, which could further enhance our understanding of disease mechanisms.
